PGY-1 Ambulatory Care/HIV Director
Patricia Poole, Pharm.D., BCPS, AAHIVP
At UCDMC since: 1988
Program Director since: 2008
Dr. Poole has worked within the UC Davis Health System (UCDHS) in numerous capacities over her 24 year career and has had a range of clinical practices ranging from pulmonary/critical care medicine to the ambulatory care of HIV patients. Throughout this time, she has precepted, taught and mentored pharmacy and medical students and residents. She developed a new ASHP accredited pharmacy residency program in HIV ambulatory care, where she has served as director since 2008. She is also coordinator for the UC Davis PGY-2 Pharmacy Resident in Ambulatory Care which started in 2012. She has been recognized as a Fellow of CSHP, a Board Certified Specialist in Pharmacotherapy and a Pharmacist Expert by the American Academy of HIV Medicine. She recently participated in a grant-funded program to assess the impact of a clinical pharmacist and clinical nurse in management of high risk heart failure patients at UCDHS.
Kathleen Haight, Patricia L. Poole, Chin-Shang Li.Addressing Virologic Failure in HIV Patients Through the Patient Centered Medical Home Model. IDWeek 2013 (October) 2013, San Francisco, CA.
Jennifer Nguyen, Patricia Poole, Sharon Myers, Kathleen Tong, Erin Griffin, Bridget Levich. Impact of a Collaborative Heart Failure Pharmacist and Nurse Pilot Project in the UC Davis Health System Primary Care Network.Heart Failure Society of American Annual Conference (September) 2013.
Patricia Parker, Patricia Poole, John Grubbs. Residency Interviews Re-Imagined. ASHP National Pharmacy Preceptors Conference (August) 2013. Washington, DC.
Rory Okasaki Gutierrez, Patricia Poole, and David Asmuth. Prevalence of Subclinical Iatrogenic Cushing’s Syndrome in Patient’s Being Co-Administered Ritonavir and Corticosteroids via Inhaled, Intranasal, and/or Topical Route. XIX International AIDS Conference (July) 2012, Washington DC.
Lawal A, Poole P. Retrospective Evaluation of Methadone and Cardiac Conductions Side Effects in HIV positive patients.ASHP Midyear Clinical Meeting (Dec) 2009, UHC Annual Meeting.
Quezada V; Siddiqui J; Poole P. Polypharmacy in the management of Human Immunodeficiency Virus (HIV) patients.ASHP Midyear Clinical Meeting (Dec) 2008, UHC Annual Meeting.
Romac DR, Poole PL: Phasing out midazolam at a University Teaching Hospital. 32nd ASHP Midyear Clinical Meeting 32:P-242D (Dec) 1997.
Poole PL, Romac DR: Erythropoietin in the Treatment of Anemia Related to Myelodysplasia. 31st ASHP Midyear Clinical Meeting, December, 1996.
Poole PL, Romac DR, King JH: Cost-Effective Management of Sedation with Intravenous Benzodiazepines and Propofol Continuous Infusions. 30th ASHP Midyear Clinical Meeting, December, 1995.
Poole, P: Pantoprazole, Formulary Review. Am J Health-Syst Pharm Jun 1, 2001;58:999-1008. Poole, PL: Pantoprazole. UHC Drug Monograph 2000:
Romac, DR, Poole PL: The role of the pharmacist in anticoagulant therapy: Patient education and counseling. Health Notes 1999: 1:3.
Romac DR, Poole PL, Owings JT, et al: Development of Guidelines for Biotechnology Drug Use as a Tool in Formulary Management: Antithrombin III. Hospital Formulary, 1995;30:9.
Poole PL: Medication Formulary Management: Future Trends. Drug Perspectives 1995;17:1.
Poole PL: Preferential Use of Diazepam (Valium) as the Intravenous Benzodiazepine of Choice. Drug Perspectives 1995;17:1.
Poole PL, Branch JM: Use of intravenous benzodiazepines and propofol at UCDMC. Drug Perspectives 1993:16:4.
Poole PL: Pancreatic enzyme supplements. Drug Perspectives 1989;12:7.
Poole PL: How pharmacy associations protect members' livelihood, future - Commentary. California Pharmacist 1988;9:20.